MiniMed 780G System Use in Type 1 Diabetes During Ramadan Intermittent Fasting: A Systematic Literature Review and Expert Recommendations
Elbarbary N, Alguwaihes A, Zarif H, Hassanein M, Deeb A, Petrovski G, Al Dahash R, Alamoudi R, Hussain S, Ibrahim M, Shaikh S, Zainudin SB, Chaar W, van den Heuvel T, Al-Sofiani ME
Diabetes technology & therapeutics · 7 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Revisión sistemática (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2024-07-25 · Diabetes Technol Ther · vol. 27 · número 1 · págs. 72–85
- Editorial
- Mary Ann Liebert, Inc.
- Citado
- 12 citas · más que el 77% de estudios similares · 1.1× el promedio de su campo
- Referencias
- 35 trabajos
- Acceso
- Acceso abierto (revista híbrida) · CC-BY
- Áreas de investigación
- Diabetes Management and Research · Dietary Effects on Health · Diabetes Management and Education
- Palabras clave
- MiniMed 780G, type 1 diabetes, Ramadan fasting, intermittent fasting, artificial pancreas, continuous glucose monitoring, glycemic control, hypoglycemia, diabetic ketoacidosis, time in range
- MeSH
- humans, diabetes mellitus, type 1, hypoglycemia, insulin, blood glucose, hypoglycemic agents, insulin infusion systems, fasting, islam, intermittent fasting
15 autores
- Nancy Samir Elbarbary🇪🇬Ain Shams University
- Abdullah M. Alguwaihes🇸🇦King Saud University
- HAWAZEN A. ZARIF🇸🇦King Saud bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City; National Guard Health Affairs
- Mohammed Hassanein🇦🇪Dubai Hospital; Mohammed Bin Rashid University of Medicine and Health Sciences
- Asma Deeb🇦🇪Khalifa University of Science and Technology; Sheikh Shakhbout Medical City
- Goran Petrovski🇶🇦🇺🇸Sidra Medical and Research Center; Weill Cornell Medical College in Qatar; Weill Cornell Medicine
- Raed Aldahash🇸🇦King Saud bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City; National Guard Health Affairs
- Reem Al Amoudi🇸🇦King Saud bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City; National Guard Health Affairs
- Sufyan Hussain🇬🇧King's College London; Guy's and St Thomas' NHS Foundation Trust; Kings Health Partners
- Mahmoud Ashraf Ibrahim
- Shehla Sajid Shaikh🇮🇳Saifee Hospital
- Sueziani Binte Zainudin🇸🇬Sengkang General Hospital
- Wael Chaar
- Tim R. A. van den Heuvel🇨🇭Medtronic (Switzerland)
- Mohammed E. Al‐Sofiani🇺🇸🇸🇦Johns Hopkins University; King Saud University
Resumen
El texto original del estudio, en el idioma en que se publicó.
This article offers a systematic literature review (SLR) on the use of the MiniMed 780G automated insulin delivery system (MM780G) in people with type 1 diabetes (PwT1D) during Ramadan intermittent fasting. It also presents consensus recommendations on the use of MM780G during the Ramadan period. The SLR was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology. The recommendations resulted from a consensus-forming process involving a panel of experts. The process considered evidence found in the SLR as well as the expert opinions. In total, six studies were included in the SLR. The evidence and expert opinions led to recommendations related to (a) pre-Ramadan counseling of MM780G users who plan to fast; (b) suggested MM780G settings, meal announcement strategy, and safety aspects during Ramadan (including a contingency plan); and (c) post-Ramadan transition into and out of Eid-al-Fitr festivities. The SLR findings showed that the MM780G maintains glycemic control at target in PwT1D during Ramadan (meeting continuous glucose monitoring-based clinical targets proposed by the International Consensus on Time-in-Range) while ensuring low rates of hypoglycemia and diabetic ketoacidosis. Automated insulin delivery also helps PwT1D fast more days of Ramadan compared with users of other less advanced modalities of treatment. Pre-Ramadan guidance on specific aspects of the MM780G along with the International Diabetes Federation and Diabetes and Ramadan International Alliance counseling guidelines is recommended. There is still a challenge with post-Iftar hyperglycemia, which could potentially be mitigated by following the recommendations outlined in this article.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.